Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual Roles of MAIT Cells in the Tumor Microenvironment: Implications for Cancer Immunity and Therapy. | Immune Netw | 2026 | 41800021 | PubTator, text mining | PubMed |
| RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms. | iScience | 2026 | 41797923 | PubTator, text mining | PubMed |
| HBx Promotes Liver Cancer Cells to Escape NK-92 Cell Attack by Mediating ADAM10 to Enzyme Cut MICA/B Shedding From Cancer Cell Membrane. | J Cell Mol Med | 2026 | 41792898 | PubTator, text mining | PubMed |
| Lactoferrin blocks orthopoxvirus entry via heparan sulphate and regulates host antiviral pathways. | Emerg Microbes Infect | 2026 | 41790953 | PubTator, text mining | PubMed |
| Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets. | Rev Cardiovasc Med | 2026 | 41789342 | PubTator, text mining | PubMed |
| Combining advanced radiotherapy techniques and immunotherapy: immunomodulatory mechanisms and clinical prospects. | Front Immunol | 2026 | 41789104 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Neuropilin-2 Deficiency Promotes Mitochondrial Dysfunction and NAD⁺-Dependent Cellular Senescence in Retinal Degeneration. | Invest Ophthalmol Vis Sci | 2026 | 41784335 | PubTator, text mining | PubMed |
| Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions. | Neurooncol Adv | 2026 | 41773179 | PubTator, text mining | PubMed |
| IL-33-Driven Macrophage Reprogramming as a Potential Immunometabolic Strategy for Herpes Simplex Keratitis. | Pharmaceuticals (Basel) | 2026 | 41754825 | PubTator, text mining | PubMed |
| Explorative Insights into Local Immune Response to BK Virus-A Cross-Sectional Study in Urine Samples Between Transplant Recipients and Non-Immunocompromised Hosts. | Medicina (Kaunas) | 2026 | 41752640 | PubTator, text mining | PubMed |
| The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications. | Molecules | 2026 | 41752527 | PubTator, text mining | PubMed |
| Integrated Single-Cell Multi-Omics Analysis Reveals That a CD8+ TPex-Monocyte Interaction Axis Coordinates Immune Infiltration in Alzheimer's Disease. | Int J Mol Sci | 2026 | 41751920 | PubTator, text mining | PubMed |
| The ADAM Family of Proteases: Structure, Substrates, and Roles in Liver Diseases. | Int J Mol Sci | 2026 | 41751763 | PubTator, text mining | PubMed |
| The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM). | Cancers (Basel) | 2026 | 41749925 | PubTator, text mining | PubMed |
| Preclinical exploration and current clinical applications of immunotherapeutic strategies for hepatocellular carcinoma. | Front Immunol | 2026 | 41743701 | PubTator, text mining | PubMed |
| Identification of Ferroptosis-Related Hub Genes and Immune Infiltration Landscape in Chronic Kidney Disease via Bioinformatics and Experimental Verification. | Immun Inflamm Dis | 2026 | 41738361 | PubTator, text mining | PubMed |
Tertiary lymphoid structures correlate with reduced recurrence risk and enhanced antitumor immunity in esophageal squamous cell carcinoma with pathologic non-complete response to neoadjuvant chemoimmunotherapy. | Exp Hematol Oncol | 2026 | 41736069 | PubTator, text mining | PubMed |
| Colorectal cancer-derived extracellular vesicles: at the crossroads of the tumor microenvironment and gut microbiota. | Front Immunol | 2026 | 41727493 | PubTator, text mining | PubMed |
| Pleiotropic immunoregulation by bile acids in pathophysiology. | Front Immunol | 2026 | 41727485 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=4